In these individuals, a sFlt-1/PlGF ratio of 38 provided good separation of women with and without the combined endpoint of preeclampsia/eclampsia/HELLP syndrome and/or MAO and/or FAO within 1 or 4 weeks (both p < 0.001; Fig. 3A). This evidence concerns the gene PGF and preeclampsia.